FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

41488111000001109: Pirfenidone 267mg tablets (Glenmark Pharmaceuticals Europe Ltd) 252 tablet 18 x 14 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 15-Mar 2023. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2887391000001110 Pirfenidone 267mg tablets (Glenmark Pharmaceuticals Europe Ltd) 252 tablet 18 x 14 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2887401000001113 Pirfenidone 267mg tablets (Glenmark Pharmaceuticals Europe Ltd) 252 tablet 18 x 14 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Pirfenidone 267mg tablets (Glenmark Pharmaceuticals Europe Ltd) 252 tablet 18 x 14 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Pirfenidone 267mg tablets (Glenmark Pharmaceuticals Europe Ltd) 252 tablet 18 x 14 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Pirfenidone 267mg tablets (Glenmark Pharmaceuticals Europe Ltd) 252 tablet 18 x 14 tablets Is a Pirfenidone 267mg tablets 252 tablet true Inferred relationship Existential restriction modifier
Pirfenidone 267mg tablets (Glenmark Pharmaceuticals Europe Ltd) 252 tablet 18 x 14 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Pirfenidone 267mg tablets (Glenmark Pharmaceuticals Europe Ltd) 252 tablet 18 x 14 tablets Has AMP Pirfenidone 267mg tablets (Glenmark Pharmaceuticals Europe Ltd) true Inferred relationship Existential restriction modifier
Pirfenidone 267mg tablets (Glenmark Pharmaceuticals Europe Ltd) 252 tablet 18 x 14 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Pirfenidone 267mg tablets (Glenmark Pharmaceuticals Europe Ltd) 252 tablet 18 x 14 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Pirfenidone 267mg tablets (Glenmark Pharmaceuticals Europe Ltd) 252 tablet 18 x 14 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Pirfenidone 267mg tablets (Glenmark Pharmaceuticals Europe Ltd) 252 tablet 18 x 14 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Pirfenidone 267mg tablets (Glenmark Pharmaceuticals Europe Ltd) 252 tablet 18 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Pirfenidone 267mg tablets (Glenmark Pharmaceuticals Europe Ltd) 252 tablet 18 x 14 tablets Has specific active ingredient Pirfenidone true Inferred relationship Existential restriction modifier
Pirfenidone 267mg tablets (Glenmark Pharmaceuticals Europe Ltd) 252 tablet 18 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start